Head of Clinical Image Analysis Applications
Are you the new Head Of Clinical Image Analysis at Visiopharm?
Your new company
Visiopharm is a privately-owned global biopharmaceutical company focused on pathology solutions for tissue-diagnostics and research. Visiopharm is a world leader in Augmented Pathology and newest advancements in artificial intelligence. In August 2018, ATP, Vækstfonden and C.L. Davids Fond invested 100 mio. DKK in Visiopharm to secure a continuous growth and development of the software for the use of cancer diagnostics.
Your new role
On behalf of our client, Visiopharm, Hays is offering a unique role as Head of Clinical Image Analysis Applications (HoCIAA). As this is a newly created position, it creates the ability to shape the role within your expertise and technical understanding. The role will be a split between management activities and practical hands-on deliverance on projects. You will be heading a team of two Image Analysis Specialists to accomplish product roadmap deliveries. In addition to managing a team, leading the development, verification and validation of products supporting the clinical applications portfolio will also be part of your responsibilities. Additionally, you will be delivering proper documentation of development and validation activities while maintaining and improving Visiopharm´s design control process in regulation to IVDR. This is done by working in close collaboration with RA, QA, Product Management and Visiopharm´s Chief Science Officer to fulfil the clinical strategy.
What you’ll need to succeed
The preferred candidate possesses an educational background within IT, Engineering, product development or similar. You possess a minimum of 3-5 years of experience working with design control processes for medical devices/IVD products specified by ISO 13485. In addition to this you hold an excellent track record within developing software products and working with EN 62304. Knowledge of external audits and image analysis software is an advantage.
As Visiopharm´s new Head of Clinical Image Analysis Applications it is vital that you bring an entrepreneurial mind-set and a strong personal drive in order to successfully enter the company. You possess a proactive, relationship-building and reflective mind-set, and you thrive in a science-driven and ambitious environment. As a professional and person you are a strong collaborator who can lead multiple projects with a high level of energy and “can do” attitude.
What you’ll get in return
The position provides the opportunity to work in a truly dynamic and dedicated organization and to influence the direction of the company. Visiopharm emphasizes an entrepreneurial culture, which allows for their employees to develop both personally and professionally. Your talent, experience and ability to influence the agenda will be valued.
What you need to do now
If you are interested in this role, forward a copy of your CV and cover letter in English and in one document. If you have any questions you are welcome to contact Senior Recruitment Consultant Anders Schelde-Jensen.
Hays Denmark is part of Hays Plc, which is listed on London Stock Exchange (FTSE 250). Hays Plc is the world's leading recruiting experts in qualified, professional and skilled work.
We operate across the private and public sectors, dealing in permanent positions, contract roles and temporary assignments. We are market leaders in the UK and Australia, and one of the market leaders in Continental Europe. As of September 2011, the Group employed 7,600 staff operating from 255 offices in 31 countries across 20 specialisms.
Our combination of deep expertise across a wide spectrum of specialised industries and professions makes us unparalleled recruiters in the world of work.
Hays Specialist Recruitment A/S has operated in Denmark since 2008. We specialise in following areas of specialism: Accountancy & Finance, Banking, Construction & Property, Engineering, HR, Insurance, IT, Legal, Logistics, Life Sciences and Sales & Marketing. For more information see www.hays.dk
Read more about Hays - click here